Boston Scientific Corp
(NYSE:BSX)
$
91.07
1.21 (1.35%)
Market Cap: 132.44 Bil
Enterprise Value: 140.10 Bil
PE Ratio: 74.26
PB Ratio: 6.39
GF Score: 84/100 Boston Scientific Corp at Wells Fargo Healthcare Conference Transcript
Sep 05, 2019 / 12:35PM GMT
Release Date Price:
$42.61
(+1.33%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst
Larry Biegelsen, the medical device analyst at Wells Fargo, and it's my pleasure to host this session with the management team from Boston Scientific. With us, we have Mike Mahoney, the CEO; and Susie Lisa, Vice President of Investor Relations. The format is going to be a fireside chat. If anybody has a question in the audience, please raise your hand.
So Mike and Susie, thank you very much for being here.
Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO
Thank you. Good morning.
Susan Vissers Lisa
Boston Scientific Corporation - VP of IR
Thanks, Larry.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst
So Mike, I thought we'd start at a high level and then dive down into some of the individual businesses. So Mike, we've gotten a little spoiled since you've been CEO. It's been a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot